About Leo Cancer Care
Leo Cancer Care is a company based in Sydney (Australia) founded in 2014 by Thomas Rock Mackie. It operates as a HealthTech. Leo Cancer Care has raised $65.3 million across 3 funding rounds from investors including Cone Health, Macmillan Cancer Support and McLaren Health Care. Leo Cancer Care offers products and services including Marie and Grace. Leo Cancer Care operates in a competitive market with competitors including RefleXion, Alpha Tau Medical, Mevion Medical Systems, ZAP-X and Starget Pharma, among others.
- Headquarter Sydney, Australia
- Founders Thomas Rock Mackie
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Leo Cancer Care Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$65.3 M (USD)
in 3 rounds
-
Latest Funding Round
$40 M (USD), Series D
Sep 24, 2025
-
Investors
Cone Health
& 11 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Leo Cancer Care
Leo Cancer Care offers a comprehensive portfolio of products and services, including Marie and Grace. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Upright particle therapy solution for cancer treatment innovation.
Upright photon therapy system for enhanced patient comfort.
Unlock access to complete
Funding Insights of Leo Cancer Care
Leo Cancer Care has successfully raised a total of $65.3M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $40 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series D — $40.0M
-
First Round
First Round
(20 Jul 2021)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2025 | Amount | Series D - Leo Cancer Care | Valuation | Catalio Capital Management |
|
| Jun, 2024 | Amount | Series C - Leo Cancer Care | Valuation | McLaren Health Care , Cone Health |
|
| Jul, 2021 | Amount | Series B - Leo Cancer Care | Valuation | Pureland Group , Alumni Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Leo Cancer Care
Leo Cancer Care has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Cone Health, Macmillan Cancer Support and McLaren Health Care. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology startups are funded by Pureland Group through venture capital.
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in innovative founders by Yu Galaxy.
|
Founded Year | Domain | Location | |
|
Venture capital investing and portfolio management services for accredited investors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Leo Cancer Care
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Leo Cancer Care
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Leo Cancer Care Comparisons
Competitors of Leo Cancer Care
Leo Cancer Care operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RefleXion, Alpha Tau Medical, Mevion Medical Systems, ZAP-X and Starget Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biology-guided radiotherapy systems are provided for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Radiotherapy technique for solid tumors is developed using alpha-emitting seeds.
|
|
| domain | founded_year | HQ Location |
Proton therapy systems are supplied for cancer radiation treatment.
|
|
| domain | founded_year | HQ Location |
Developer of gyroscopic radiosurgery platform
|
|
| domain | founded_year | HQ Location |
Targeted radiopharmaceuticals are developed for solid tumor treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Leo Cancer Care
Frequently Asked Questions about Leo Cancer Care
When was Leo Cancer Care founded?
Leo Cancer Care was founded in 2014 and raised its 1st funding round 7 years after it was founded.
Where is Leo Cancer Care located?
Leo Cancer Care is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Who is the current CEO of Leo Cancer Care?
Stephen Towe is the current CEO of Leo Cancer Care.
Is Leo Cancer Care a funded company?
Leo Cancer Care is a funded company, having raised a total of $65.3M across 3 funding rounds to date. The company's 1st funding round was a Series B of $25.3M, raised on Jul 20, 2021.
What does Leo Cancer Care do?
Radiation therapy solutions are provided by Leo Cancer Care with a focus on upright positioning for improved patient experience. Advanced technologies in particle and photon therapy are offered through products like Marie and Grace. The healthcare sector is targeted, specifically in cancer treatment, aiming to make radiotherapy more accessible and cost-effective. Compatibility with fixed radiation beams is ensured to unlock various treatment modalities. Patient comfort and economic efficiency are prioritized in the design of these systems.
Who are the top competitors of Leo Cancer Care?
Leo Cancer Care's top competitors include RefleXion, Alpha Tau Medical and Starget Pharma.
What products or services does Leo Cancer Care offer?
Leo Cancer Care offers Marie and Grace.
Who are Leo Cancer Care's investors?
Leo Cancer Care has 12 investors. Key investors include Cone Health, Macmillan Cancer Support, McLaren Health Care, Cosylab, and Pureland Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.